Motzer R J, Reuter V E, Cordon-Cardo C, Bosl G J
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
Cancer Res. 1988 Sep 15;48(18):5342-7.
With the use of immunohistochemical techniques, seven mouse monoclonal antibodies and the lectin from Ulex europaeus, detecting blood group antigens of the ABH and Lewis systems, have been used to define the distribution of these antigenic structures in germ cell tumors. The reagents used recognize the following blood group antigens: A, B, H, Lewisa, Lewisb, X (Lewisx), Y (Lewisy), and type I precursor antigen. Tumors from 29 patients were studied. Tumors studied consisted of pure embryonal carcinoma for eight patients, pure yolk sac tumor for two patients, embryonal carcinoma plus yolk sac tumor in one patient, and yolk sac tumor plus seminoma in one patient. Also studied were nine classic seminomas and a group of six patients with tumors classified as seminomas that exhibited atypical histological features. One patient had an anaplastic carcinoma arising from the mediastinum which could not be conclusively identified as a germ cell tumor morphologically and was analyzed separately. All embryonal carcinomas and yolk sac tumors exhibited strong positivity for type I precursor structure as detected by the K-21 monoclonal antibody. In marked contrast, there was non staining in classic seminomas but heterogeneous staining in five of six atypical seminomas. The majority of embryonal carcinomas and all yolk sac tumors studied demonstrated strong positivity for blood group antigen H. For seminoma, however, only one of the atypical cases and two of the classic cases (occasional cells) stained for H. Focal expression of the Y antigen was identified in 5 of 17 seminomas and in the majority of embryonal carcinomas and yolk sac tumors. Two yolk sac tumors and two classic seminomas expressed blood group X. The remaining blood group antigens were not expressed by seminomas while they were variably expressed by embryonal carcinoma and yolk sac tumors. These data suggest that K-21 and blood group antigen H may be distinguishing markers of nonseminomatous germ cell tumor versus seminoma. If so, it is possible that the heterogeneous expression of blood group substances in seminomas with atypical histologies is an indication of differentiation towards nonseminomatous germ cell tumor.
运用免疫组织化学技术,七种小鼠单克隆抗体以及来自欧洲荆豆的凝集素(用于检测ABH和Lewis系统的血型抗原)已被用于确定这些抗原结构在生殖细胞肿瘤中的分布。所使用的试剂可识别以下血型抗原:A、B、H、Lea、Leb、X(Lex)、Y(Ley)和I型前体抗原。对29例患者的肿瘤进行了研究。所研究的肿瘤包括8例纯胚胎癌患者、2例纯卵黄囊瘤患者、1例胚胎癌加卵黄囊瘤患者以及1例卵黄囊瘤加精原细胞瘤患者。还研究了9例经典精原细胞瘤以及一组6例被归类为精原细胞瘤但具有非典型组织学特征的患者。1例患者患有源自纵隔的间变性癌,在形态学上无法明确鉴定为生殖细胞肿瘤,因此单独进行了分析。所有胚胎癌和卵黄囊瘤通过K - 21单克隆抗体检测显示对I型前体结构呈强阳性。与之形成鲜明对比的是,经典精原细胞瘤无染色,但6例非典型精原细胞瘤中有5例呈异质性染色。大多数胚胎癌和所有研究的卵黄囊瘤对血型抗原H呈强阳性。然而,对于精原细胞瘤,仅1例非典型病例和2例经典病例(偶尔细胞)对H染色。在17例精原细胞瘤中的5例以及大多数胚胎癌和卵黄囊瘤中发现了Y抗原的局灶性表达。2例卵黄囊瘤和2例经典精原细胞瘤表达血型抗原X。其余血型抗原在精原细胞瘤中未表达,而在胚胎癌和卵黄囊瘤中呈可变表达。这些数据表明,K - 21和血型抗原H可能是非精原性生殖细胞肿瘤与精原细胞瘤的鉴别标志物。如果是这样,具有非典型组织学的精原细胞瘤中血型物质的异质性表达可能是向非精原性生殖细胞肿瘤分化的一个指标。